Title
Category
Credits
Event date
Cost
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Yuri Fedoriw, MD, provides a general background of cancer pathology and tissue diagnosis. The development of testing methods and their application will be discussed, as will the limitations and challenges of cancer classification.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Samuel Cykert, MD, and Christina Yongue, MPH, MCHES, describe the long-lasting racial disparities in breast and lung cancer care, and some of the root causes for these inequities. Participants will learn how a community-academic-medical partnership addressed these disparities by designing system-change interventions based on antiracism principles.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Farrell Wiggins MS, OTR/L, and Alexis Petteway, MS, OTR/L, provide insight into Occupational Therapy’s unique role in cancer rehabilitation. They explore the benefits of receiving OT in both the inpatient and outpatient settings. Importantly, they also discuss the how occupational therapists measure and address cancer and chemotherapy related symptoms and occupational challenges in cancer survivors.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Patti Morfeld, RN, BSN, OCNm discusses how to provide patient centered care for LGBTQ patients and families from registration through diagnosis, treatment and survivorship.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Cindy Kelly, FNP-BC, ACHPN, and Vineeta Rao, PharmD, BCPS, review opioid and nonopioid treatment options for cancer-related pain. Their presentation addresses patients with cancer and substance use disorder and also cancer patients that are in remission, but who still present with persistent pain.
  • Advanced Practice Provider
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Immunotherapy has made tremendous progress as cancer-directed therapy has evolved, particularly in the field of T cell-engaging therapies. Common and serious side effects of these types of therapies include Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS). Join us as Bejal Kikani, MSN, FNP-BC, WHNP-BC, discusses the recognition, grading, and treatment of these toxicities.
  • Advanced Practice Provider
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Jeremiah 'Jig' Deneve, DO, FACS, provides an overview of the natural history, treatment, and outcome for peritoneal carcinomatosis.
  • Advanced Practice Provider
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Megan McElfresh, PA-C, will review chimeric antigen receptor therapy, associated side effects, and the treatment or prevention of side effects.
  • Advanced Practice Provider
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
This multidisciplinary Panel Presentation will describe the importance of CT-based lung cancer screening, indications and criteria for screening, the optimal structure and requirements of a screening program, and the current state of screening at UNC. We will present practical information relevant to providers who may order screening CT and/or may discuss screening with patients.
  • Advanced Practice Provider
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Allison Phillips, MPAP, MHPE, PA-C, reviews the clinical manifestations, underlying causes, and management of some of the most common emergencies facing patients undergoing cancer treatment, including Superior Vena Cava Syndrome, Hypercalcemia, and SIADH.

Pages